Description:
VolitionRx Limited (VNRX) is an innovative multinational epigenetics company based in Austin, Texas, dedicated to developing blood-based diagnostic tests aimed at improving cancer detection and other disease diagnoses globally. Utilizing its proprietary Nu.Q™ platform, VolitionRx focuses on creating advanced, non-invasive diagnostic solutions that seek to enhance patient outcomes through early disease detection. Positioned at the cutting edge of the expanding epigenetics market, the company is strategically positioned to address the increasing demand for accurate and reliable diagnostic tools in oncology and beyond, signaling significant growth potential.
Industry:
MEDICAL DEVICES
Address:
1489 WEST WARM SPRINGS ROAD, HENDERSON, NV, UNITED STATES, 89014
Fiscal year end:
December
Market capitalization:
$43 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
14 years:
-83%
How much will you get:
$174
Prices dates:
11-10-2011: $2.50 and 31-10-2025: $0.43